Pneumococcal Vaccines Market, By Vaccine Type (Conjugate Vaccine, Polysaccharide Vaccine), By Product Type (Prevnar 13, Synflorix, Pneumovax23), By Region (North America, Europe, Asia Pacific, Middle East & Africa, And South America) – Market Size & Forecasting To 2028

The Pneumococcal Vaccines Market report points out national and global business prospects and competitive conditions for pneumococcal vaccines. Market size estimation and forecasts were given based on a detailed research methodology tailored to the conditions of the demand for pneumococcal vaccines. The pneumococcal vaccines market has been segmented by vaccine type (conjugate vaccine, polysaccharide vaccine), by product type (prevnar 13, synflorix, pneumovax23). Historical background for the demand of pneumococcal vaccines has been studied according to organic and inorganic innovations in order to provide accurate estimates of the market size. Primary factors influencing the growth of the demand pneumococcal vaccines have also been established with potential gravity. Major regions covered in the study include North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Market Segmentation:

By Vaccine Type:

  • Conjugate Vaccine
  • Polysaccharide Vaccine

By Product Type:

  • Prevnar 13
  • Synflorix
  • Pneumovax23

By Region:

North America Pneumococcal Vaccines Market

  • North America, by Country
    • US
    • Canada
    • Mexico
  • North America, by Vaccine Type
  • North America, by Product Type

Europe Pneumococcal Vaccines Market

  • Europe, by Country
    • Germany
    • Russia
    • UK
    • France
    • Italy
    • Spain
    • The Netherlands
    • Rest of Europe 
  • Europe, by Vaccine Type
  • Europe, by Product Type

Asia Pacific Pneumococcal Vaccines Market

  • Asia Pacific, by Country
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Rest of Asia Pacific 
  • Asia Pacific, by Vaccine Type
  • Asia Pacific, by Product Type

Middle East & Africa Pneumococcal Vaccines Market

  • Middle East & Africa, by Country 
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East & Africa
  • Middle East & Africa, by Vaccine Type
  • Middle East & Africa, by Product Type

South America Pneumococcal Vaccines Market

  • South America, by Country 
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • South America, by Vaccine Type
  • South America, by Product Type

Major Companies: GlaxoSmithKline plc, Pfizer Inc., CSL Ltd., Merck & Co., Inc., Serum Institute of India Pvt. Ltd., Sanofi Pasteur Inc.

Years Covered in the Study:

Historic Year: 2017-2018

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2028

Objectives of this report:

  • To estimate market size for pneumococcal vaccines market on regional and global basis.
  • To identify major segments in pneumococcal vaccines market and evaluate their market shares and demand.
  • To provide a competitive scenario for the pneumococcal vaccines market with major developments observed by key companies in the historic years.
  • To evaluate key factors governing the dynamics of pneumococcal vaccines market with their potential gravity during the forecast period.

Reasons to Buy This Report:

  • Provides niche insights for decision about every possible segment helping in strategic decision making process.
  • Market size estimation of the pneumococcal vaccines market on a regional and global basis.
  • A unique research design for market size estimation and forecast.
  • Identification of major companies operating in the market with related developments
  • Exhaustive scope to cover all the possible segments helping every stakeholder in the pneumococcal vaccines.

Customization:

This study is customized to meet your specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country
  • Product Specific Competitive Analysis

For more information, contact: sales@quincemarketinsights.com